President Moon Meets Novavax CEO to Discuss 'Vaccine Sovereignty'

SK Bioscience President Also Accompanies to Cheongwadae... Interest in Securing Novavax Vaccine Through Technology Transfer Method

[Asia Economy Reporter Ryu Jeong-min] On the afternoon of the 27th, President Moon Jae-in met with Stanley Erck, CEO of Novavax, at the Blue House to discuss progress related to securing vaccine sovereignty.

The Korean government and Novavax are seeking to find common ground that benefits both parties amid the resurgence of COVID-19.

Park Kyung-mi, spokesperson for the Blue House, stated that "President Moon will exchange opinions on expanding cooperation for vaccine production with Novavax and discuss expedited approval applications." Although the Blue House refrains from specific comments, it is anticipated that the discussion will go beyond merely securing additional vaccines.

[Image source=Yonhap News]

From the Korean government's perspective, the discussion is expected to focus on measures that help secure vaccine sovereignty, while from Novavax's viewpoint, it will aid in competing with other vaccine manufacturers. This is why it is analyzed that more advanced details regarding Novavax production through technology transfer will be discussed.

The meeting between President Moon and CEO Erck is scheduled to take place from 3:00 PM for 30 minutes. Attending the meeting will be Sung Yun-mo, Minister of Trade, Industry and Energy; Kwon Deok-cheol, Minister of Health and Welfare; Lee Tae-han, Senior Secretary for Social Affairs at the Blue House; and Ryu Geun-hyeok, Secretary for Social Policy.

From SK's side, Choi Chang-won, Vice Chairman of SK Discovery, and Ahn Jae-yong, President of SK Bioscience, will attend. Spokesperson Park announced that the details of the discussion will be disclosed after CEO Erck's meeting concludes.

This content was produced with the assistance of AI translation services.